|
The Centers for Medicare and
Medicaid Services has posted new
IVIG reimbursement Q codes and rates for the
third quarter of 2007, effective
July 1, 2007 through September 30,
2007. The chart below compares the
second quarter rates to the new
rates.
The
new third quarter rates represent an
increase of about 4.3 percent for
lyophilized IVIG (powdered) and 2.0
to 9.5 percent for liquid IVIG
products, which now have individual
codes.
Throughout 2007, Medicare will continue the temporary,
separate payment to physicians and
hospital outpatient departments for
pre-administration services
associated with administration of
IVIG. The IVIG pre-administration
service payment is in addition to
Medicare's payments to the physician
or hospital for the IVIG product
itself and for administration of the
IVIG product via intravenous
infusion.
New IVIG Codes and Reimbursement Rates Effective July 1, 2007
|
Code |
Product |
Unit |
New Q3 Rates |
Q2 Rates |
|
Q4087 |
Octagam injection |
500 MG |
$33.483 |
$30.571 |
|
Q4088 |
Gammagard liquid
injection |
500 MG |
$31.197 |
$30.571 |
|
Q4091 |
Flebogamma injection |
500 MG |
$32.614 |
$30.571 |
|
Q4092 |
Gamunex injection |
500 MG |
$31.860 |
$30.571 |
|
J1566 |
Immune globulin, powder |
500 MG |
$26.828 |
$25.720 |
|
G0332 |
Physician and hospital
outpatient department
pre-administration fee |
Per infusion encounter |
Remains the same as last quarter
|
|
